LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK | Zendy

Gong Zhang | Zendy; Ximin Chen | Zendy; Lei Ma | Zendy; Rui Ding | Zendy; Lihong Zhao | Zendy; Feng Ma | Zendy; Xubin Deng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK

Author(s) -

Gong Zhang,

Ximin Chen,

Lei Ma,

Rui Ding,

Lihong Zhao,

Feng Ma,

Xubin Deng

Publication year - 2020

Publication title -

aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 90

ISSN - 1945-4589

DOI - 10.18632/aging.103321

Subject(s) - ezh2 , cancer research , hepatocellular carcinoma , long non coding rna , carcinogenesis , methylation , metastasis , biology , histone , cell growth , cell culture , rna , gene , genetics , cancer

Long non-coding RNAs (lncRNAs) have been reported to play significant roles in human tumorigenesis, for example, in hepatocellular carcinoma (HCC). This study explored the role of LINC01419, a new lncRNA, in HCC. In vitro study revealed that LINC01419 promotes growth and migration of HCC cells. Genes that affected cell proliferation and cell migration were identified using RNA-sequence. Subsequently, it was confirmed that LINC01419 binds to EZH2, leading to histone methylation of the RECK promoter. Interaction between LINC01419 and FUS stabilized EZH2 mRNA thereby enhancing EZH2 expression. Conclusively, the results of this study confirm that LINC01419 may serve as a potential target for HCC diagnosis and treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research